A detailed history of Arrowstreet Capital, Limited Partnership transactions in Genmab A/S stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 93,628 shares of GMAB stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93,628
Previous 37,409 150.28%
Holding current value
$1.92 Million
Previous $940,000 142.77%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.84 - $28.48 $1.34 Million - $1.6 Million
56,219 Added 150.28%
93,628 $2.28 Million
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $940,088 - $1.13 Million
37,409 New
37,409 $940,000
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $25.8 Million - $32 Million
-740,684 Reduced 42.2%
1,014,533 $38.3 Million
Q4 2022

Feb 14, 2023

BUY
$33.8 - $47.06 $9.12 Million - $12.7 Million
269,691 Added 18.15%
1,755,217 $74.4 Million
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $6.01 Million - $71.3 Million
190,807 Added 14.74%
1,485,526 $47.7 Million
Q2 2022

Aug 15, 2022

BUY
$26.83 - $38.57 $11.4 Million - $16.4 Million
425,498 Added 48.95%
1,294,719 $42.1 Million
Q1 2022

May 13, 2022

BUY
$30.95 - $39.68 $10.5 Million - $13.4 Million
338,902 Added 63.91%
869,221 $31.4 Million
Q4 2021

Feb 14, 2022

BUY
$35.87 - $47.12 $3.68 Million - $4.84 Million
102,620 Added 23.99%
530,319 $21 Million
Q3 2021

Nov 12, 2021

BUY
$41.55 - $48.72 $17.4 Million - $20.4 Million
418,099 Added 4355.2%
427,699 $18.7 Million
Q2 2021

Aug 13, 2021

SELL
$32.88 - $44.57 $2.96 Million - $4.01 Million
-90,033 Reduced 90.36%
9,600 $392,000
Q1 2021

May 14, 2021

SELL
$30.92 - $44.4 $8.85 Million - $12.7 Million
-286,067 Reduced 74.17%
99,633 $3.27 Million
Q4 2020

Feb 12, 2021

SELL
$33.66 - $40.76 $3.16 Million - $3.83 Million
-93,895 Reduced 19.58%
385,700 $15.7 Million
Q3 2020

Nov 12, 2020

SELL
$33.07 - $38.68 $8.27 Million - $9.68 Million
-250,174 Reduced 34.28%
479,595 $17.6 Million
Q2 2020

Aug 12, 2020

BUY
$20.05 - $33.89 $1.03 Million - $1.74 Million
51,467 Added 7.59%
729,769 $24.7 Million
Q1 2020

May 15, 2020

BUY
$17.15 - $25.22 $5.64 Million - $8.29 Million
328,880 Added 94.12%
678,302 $14.4 Million
Q4 2019

Feb 13, 2020

BUY
$18.88 - $24.14 $4.61 Million - $5.9 Million
244,317 Added 232.45%
349,422 $7.8 Million
Q3 2019

Nov 14, 2019

BUY
$18.0 - $21.38 $1.89 Million - $2.25 Million
105,105 New
105,105 $2.13 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.